Concepedia

Giles Dixon

GD

15

Publications

1.8K

Citations

14

H-Index

2011

Active since

Affiliations

Nottingham University Hospitals NHS Trust(Current)

University of Bristol

University of Sheffield

North Bristol NHS Trust

University of Oxford

Giles Dixon is an author at Nottingham University Hospitals NHS Trust specializing in clinical trials, medicine, and covid-19.

ORCID

Top concepts

Publications per year

2011–2024

15

Publications

15

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model

Philip M. Elks, Fredericus J. van Eeden, Giles Dixon et al. · Blood · 2011 · 242 citations

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 126 citations · Full text

Rows per page

1–5 of 15